Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study, published in the International Journal of Molecular Science ...

Age-related decline is not an unavoidable fate, but a problem that can be addressed with modern medicine, writes .

Scientists have discovered that a small fruit from the Amazon rainforest could one day help improve cancer treatment. The fruit, called camu-camu, has been used for generations by people living in the ...

Wildlife conservationists are raising awareness over Pangolins, shy and scaly creatures native to Africa and Asia, for World Pangolin Day on Saturday. The pango ...

Colon cancer survivor Vivian Chee has had three lung surgeries since 2021 but continues to keep fit. Read more at straitstimes.com. Read more at straitstimes.com.

Dietary supplements are wildly popular, but large clinical trials and other research by Cancer Center shows many common dietary supplements offer little proven benefit for cancer prevention, and in ...

One of the most curable forms of blood cancer is Acute promyelocytic leukemia (APL). For decades, doctors have been able to ...

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

Cancer-related NHS hospital care costs by stage at diagnosis differed between cancer types; this heterogeneous pattern could inform detailed and nuanced economic evaluations of early detection ...

Retevmo improved event-free survival in stage 2 to 3A RET fusion-positive non-small cell lung cancer after curative therapy, per phase 3 data. Retevmo (selpercatinib) significantly improved event-free ...